Company Announcements

Surescripts Introduces New Patient Experience Solution to Transform the Medication Experience and Improve Patient Access, Affordability and Adherence

ARLINGTON, Va. & SANTA MONICA, Calif.--(BUSINESS WIRE)--Jan. 13, 2026-- Surescripts®, the nation’s leading health intelligence network, introduces its Patient Experience product, Script Corner™, to transform the medication experience and empower patients by bringing together prescription benefit data, medication management and personalized engagement. Script Corner will include patient price transparency, including discounted cash prices through an exclusive partnership with GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S.

“We believe the future of healthcare is personalized, connected, and truly patient-driven,” said Frank Harvey, Chief Executive Officer of Surescripts. “Surescripts has always championed patient choice—whether it’s the pharmacy they prefer or the tools they use to manage their care. Our new Script Corner product is a bold step toward that future, empowering patients with price transparency and giving them the freedom to select the pharmacy and savings options that work best for them, including discounted cash prices through our partnership with GoodRx. By meeting patients where they are—digitally, clinically and financially—we’re simplifying the medication experience and putting meaningful choices directly in their hands.”

What is Script Corner?

• Script Corner is a mobile-friendly, web application that will empower patients with the prescription price transparency they need to affordably get and stay on treatment.
• With Script Corner, when a prescriber at a participating health system transmits an eligible electronic prescription, the patient will receive a secure text message with a personalized web link where they can choose to view prescription details.
• Script Corner is the only solution that will give patients instant visibility into the cost of their prescription at their chosen pharmacy, including their insurance copay price, GoodRx discounted cash price, as well as other available savings programs, allowing them to choose the most affordable path and helping them avoid costly surprises when they pick up their prescription.
• All pharmacies are automatically included in Script Corner as part of Surescripts' electronic prescribing—there’s no need for pharmacies to signup to be sure their price is listed.
• Over time, Script Corner will include additional functionality for patients, including medication management, help with onboarding and enrollment in patient support programs and personalized adherence alerts.
• Script Corner will be available to patients through select health systems in Illinois and Texas in late January then rolled out more broadly throughout 2026.

“Working with Surescripts allows us to reach patients at a pivotal moment, right after a prescription is written, when they’re trying to understand what it will cost,” said Wendy Barnes, President and CEO of GoodRx. “By eliminating cost surprises earlier than ever, we help more patients start and stay on therapy and ensure affordability programs reach the patients they’re intended to serve.”

Benefits Across the Healthcare Ecosystem

By integrating Surescripts’ market-leading health intelligence network with GoodRx’s proven prescription savings, Script Corner creates a more connected, efficient and affordable medication experience for the entire healthcare ecosystem:

• Patients gain upfront clarity into pricing and savings options, helping them understand the cost of their prescription and choose the option that works best for them, so they can move confidently from prescription to pick up.

• Health systems are able to give patients greater choice, which could help them avoid delays or the need to switch therapies, leading to reduced prescription abandonment and improved medication adherence.

• Pharmaceutical companies’ affordability programs can reach patients the moment they receive a prescription for a brand medication, helping more patients start and stay on therapy.

• Pharmacy benefit managers and health plans retain better visibility into their patients' prescriptions and their members quickly see the benefits-based pricing options for their medication so that they can choose the option that works best for them and ensure they adhere to their treatment plan.

• Pharmacies experience less counter friction and reduced abandonment because patients receive complete pricing information upfront and know what to expect when they arrive at the pharmacy for pick up. When integrated with the GoodRx e-commerce experience, Script Corner provides the added benefit of enabling patients to choose a GoodRx price and pay online before pickup, giving pharmacies full claim and payment details in advance and reducing reprocessing.

Addressing a National Challenge

Script Corner is designed to close long-standing gaps between prescribing and pickup that often keep patients from getting the treatments they need. In a recent survey, 87% of prescribers said patients ask to delay or change prescriptions due to out-of-pocket costs very or somewhat often. And 95% of providers believe tools to identify more affordable drug alternatives would be very or somewhat helpful in supporting more satisfying patient interactions.

GoodRx and Surescripts will discuss Script Corner in further detail at the J.P. Morgan Healthcare Conference on January 13, 2026, at 1:30 p.m. PT.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we bring healthcare together to inform and accelerate decisions, helping keep patient care on track. With the Surescripts Network Alliance®, we’re empowering the healthcare ecosystem with intelligence and interoperability for smarter, faster prescribing, prior authorization, treatment, care management and more. Visit us at surescripts.com and follow us on LinkedIn.

About GoodRx

GoodRx is the leading platform for medication savings in the U.S., used by nearly 30 million consumers and over one million healthcare professionals annually. Uniquely situated at the center of the healthcare ecosystem, GoodRx connects consumers, healthcare professionals, payers, PBMs, pharma manufacturers, and retail pharmacies to make saving on medications easier. By reducing friction and inefficiencies, GoodRx helps consumers save time and money when filling prescriptions so they can get the care they deserve. Since 2011, GoodRx has helped Americans save over $85 billion on the cost of their medications.

​GoodRx periodically posts information that may be important to investors on its investor relations website at https://investors.goodrx.com . We intend to use our website as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with the Securities and Exchange Commission (the “SEC”) and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release.

GoodRx Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding anticipated savings, convenience and accessibility; the expected benefits and value of the GoodRx and Surescripts partnership; and our plans, expectations and objectives. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks relating to our ability to achieve broad market education and change consumer purchasing habits; changes in medication pricing and pricing structures; our reliance on a limited number of industry participants; and the important factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, and our other filings with the SEC. Any such forward-looking statements are based on current expectations, projections and estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260113093588/en/

Media Contacts
Kate Giaquinto
(571) 290-6859
Kate.Giaquinto@surescripts.com
and
press@goodrx.com

Source: Surescripts